» Articles » PMID: 38366006

Comparative Evaluation of Real-time PCR and ELISA for the Detection of Human Fascioliasis

Overview
Journal Sci Rep
Specialty Science
Date 2024 Feb 16
PMID 38366006
Authors
Affiliations
Soon will be listed here.
Abstract

Fascioliasis is a zoonotic parasitic infection caused by Fasciola species in humans and animals. Despite significant advances in vaccination and new therapeutic agents, little attention has been paid to validating methods for the diagnosis of fascioliasis in humans. Serological techniques are convenient assays that significantly improves the diagnosis of Fasciola infection. However, a more sensitive method is required. The aim of this study was to compare the Real-Time PCR technique with the indirect-ELISA for the detection of Fasciola hepatica in human. Using a panel of sera from patients infected with Fasciola hepatica (n = 51), other parasitic infections (n = 7), and uninfected controls (n = 12), we optimized an ELISA which employs an excretory-secretory antigens from F. hepatica for the detection of human fascioliasis. After DNA extraction from the samples, molecular analysis was done using Real-Time PCR technique based on the Fasciola ribosomal ITS1 sequence. Of 70 patient serum samples, 44 (62.86%) samples were identified as positive F. hepatica infection using ELISA and Real-Time PCR assays. There was no cross-reaction with other parasitic diseases such as toxoplasmosis, leishmaniasis, taeniasis, hydatidosis, trichinosis, toxocariasis, and strongyloidiasis. The significant difference between the agreement and similarity of the results of patients with indirect ELISA and Real-Time PCR was 94.4% and 99.2%, respectively (Cohen's kappa ≥ 0.7; P = 0.02). Based on the Kappa agreement findings, the significant agreement between the results of ELISA and Real-Time PCR indicates the accuracy and reliability of these tests in the diagnosis of F. hepatica in humans.

References
1.
Kaya M, Bestas R, Girgin S, Cicek M, Kaplan M . Increased anti-Echinococcus granulosus antibody positivity in Fasciola hepatica infection. Turk J Gastroenterol. 2012; 23(4):339-43. DOI: 10.4318/tjg.2012.0354. View

2.
Gonzales Santana B, Dalton J, Vasquez Camargo F, Parkinson M, Ndao M . The diagnosis of human fascioliasis by enzyme-linked immunosorbent assay (ELISA) using recombinant cathepsin L protease. PLoS Negl Trop Dis. 2013; 7(9):e2414. PMC: 3777859. DOI: 10.1371/journal.pntd.0002414. View

3.
Caravedo M, Cabada M . Human Fascioliasis: Current Epidemiological Status and Strategies for Diagnosis, Treatment, and Control. Res Rep Trop Med. 2020; 11:149-158. PMC: 7705270. DOI: 10.2147/RRTM.S237461. View

4.
Arias-Pacheco C, Lucas J, Rodriguez A, Cordoba D, Lux-Hoppe E . Economic impact of the liver condemnation of cattle infected with Fasciola hepatica in the Peruvian Andes. Trop Anim Health Prod. 2020; 52(4):1927-1932. DOI: 10.1007/s11250-020-02211-y. View

5.
Cabada M, Malaga J, Castellanos-Gonzalez A, Bagwell K, Naeger P, Rogers H . Recombinase Polymerase Amplification Compared to Real-Time Polymerase Chain Reaction Test for the Detection of in Human Stool. Am J Trop Med Hyg. 2016; 96(2):341-346. PMC: 5303034. DOI: 10.4269/ajtmh.16-0601. View